Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
Eli Lilly(LLY) stock is priced at $1,156.96, giving the company a market capitalization of 1.09T. It carries a P/E multiple of 39.76 and pays a dividend yield of 0.57%.
On 2026-09-24, Eli Lilly(LLY) stock opened at $1,174.51, reached a high of —, and a low of —.
The Eli Lilly(LLY)'s current trading volume is 4.13K, compared to an average daily volume of 2.29M.
During the past year, Eli Lilly(LLY) stock moved between $712.05 at its lowest and $1,292.65 at its peak.
During the past year, Eli Lilly(LLY) stock moved between $712.05 at its lowest and $1,292.65 at its peak.
LLY News
Eli Lilly (LLY) and Company announced the U.S. Food and Drug Administration approval of Onswik, a once-weekly basal insulin, indicated along with diet and exerc...
Eli Lilly (NYSE: LLY) agreed a research collaboration and licensing deal with InnoCare Pharma to pursue up to five new medicines. The partners plan to target s...
Key Points Famous investors don’t agree on everything, but these three see the value in this particular healthcare company. This player is generating blockbus...
Analyst ratings
84%
of 32 ratingsMore LLY News
InnoCare Pharma Ltd. ( (HK:9969) ) has provided an announcement. InnoCare Pharma has entered into a strategic research collaboration and license agreement with...
Key Points Eli Lilly has a deep pipeline in its core therapeutic area. Its next-gen obesity drug, retatrutide, posted excellent results in Phase 3 studies. T...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Eli Lilly and Company has launched a new Phase 4 study in India to assess the...
Wedbush lowered the firm’s price target on Nektar (NKTR) to $50 from $80 and keeps a Neutral rating on the shares. Following “speculation on failed litigation”...
Home Depot Inc. (NYSE:HD) co-founder Ken Langone stated that Mounjaro maker Eli Lilly and Co. (NYSE:LLY) could reach a $2,000 share price within three to four y...
In some ways, Novo Nordisk (NVO -1.00%) clearly has an image problem. It effectively created the GLP-1 weight-loss drug market when it launched Wegovy. But it q...
Nektar Therapeutics (NKTR) quickly sank 11% as a jury deliberated in its patent dispute with Eli Lilly (LLY) over its Rezpeg drug. The jury in San Francisco fe...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.